Jeuveau (PRABOTULINUM TOXIN TYPE A)
Jeuveau (PRABOTULINUM TOXIN TYPE A) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Jeuveau; Generic name: PRABOTULINUM TOXIN TYPE A; Drug class: Acetylcholine Release Inhibitor [EPC].
| Brand name | Jeuveau |
|---|---|
| Generic name | PRABOTULINUM TOXIN TYPE A |
| Drug class | Acetylcholine Release Inhibitor [EPC] |
| Manufacturer | Evolus, Inc. |
| Used for | 1 INDICATIONS AND USAGE JEUVEAU is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. JEUVEAU is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Glabellar Lines Administration: 0.1 mL (4 Units) by intramuscular injection into each of five sites, for a total dose of 20 Units ( 2.2 , 2.3 ) 2.1 Instructions for Safe Use The potency Units of JEUVEAU (prabotulinumtoxinA-xvfs) for injection are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of JEUVEAU cannot be compared to nor convert |
| Warnings | WARNING: DISTANT SPREAD OF TOXIN EFFECT The effects of all botulinum toxin products, including JEUVEAU, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. JEUVEAU is not approved for the treatment of spasticity or any conditions other than glabellar lines. [ See Warnings and Precaution |
| Active ingredient(s) | BOTULINUM TOXIN TYPE A |
| Route | INTRAMUSCULAR |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a914c1-e54b-4b50-965d-b0fd9111bba4 |